Connection

Chong Yu to Risk Assessment

Back to Details
This is a "connection" page, showing publications Chong Yu has written about Risk Assessment.
Chong Yu
Connection Strength
0.059
Risk Assessment
  1. Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan. Int J Chron Obstruct Pulmon Dis. 2018; 13:3055-3063.
    View in: PubMed
    Score: 0.034
  2. Comparison of clinical and microbiological diagnoses for older adults with COVID-19 in Wuhan: a retrospective study. Aging Clin Exp Res. 2020 Sep; 32(9):1889-1895.
    View in: PubMed
    Score: 0.010
  3. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:867-874.
    View in: PubMed
    Score: 0.008
  4. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017; 12:2987-2996.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.